-
1
-
-
34250003794
-
Natural history and outcome in systemic AA amyloidosis
-
DOI 10.1056/NEJMoa070265
-
Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, PN Hawkins. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007; 356: 2361-2371. (Pubitemid 46883770)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.23
, pp. 2361-2371
-
-
Lachmann, H.J.1
Goodman, H.J.B.2
Gilbertson, J.A.3
Gallimore, J.R.4
Sabin, C.A.5
Gillmore, J.D.6
Hawkins, P.N.7
-
2
-
-
17844391059
-
Molecular and genetic characteristics of hereditary autoinflammatory diseases
-
DOI 10.2174/1568010053622957
-
Tunca M, Ozdogan H. Molecular and genetic characteristics of hereditary autoinflammatory diseases. Curr Drug Targets Inflamm Allergy. 2005; 4: 77-80. (Pubitemid 40584856)
-
(2005)
Current Drug Targets: Inflammation and Allergy
, vol.4
, Issue.1
, pp. 77-80
-
-
Tunca, M.1
Ozdogan, H.2
-
3
-
-
12344314454
-
Familial Mediterranean Fever (FMF) in Turkey: Results of a nationwide multicenter study
-
Baltimore
-
Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E. Familial Mediterranean Fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005; 84: 1-11.
-
(2005)
Medicine
, vol.84
, pp. 1-11
-
-
Tunca, M.1
Akar, S.2
Onen, F.3
Ozdogan, H.4
Kasapcopur, O.5
Yalcinkaya, F.6
Tutar, E.7
Ozen, S.8
Topaloglu, R.9
Yilmaz, E.10
Arici, M.11
Bakkaloglu, A.12
Besbas, N.13
Akpolat, T.14
Dinc, A.15
Erken, E.16
-
4
-
-
0034658465
-
The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators
-
Centola M,Wood G, Frucht DM, Galon J, Aringer M, Farrell C, Kingma DW, Horwitz ME, Mansfield E, Holland SM, O'Shea JJ, Rosenberg HF, Malech HL, Kastner DL. The gene for Familial Mediterranean Fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000; 95: 3223-3231. (Pubitemid 30321178)
-
(2000)
Blood
, vol.95
, Issue.10
, pp. 3223-3231
-
-
Centola, M.1
Wood, G.2
Frucht, D.M.3
Galon, J.4
Aringer, M.5
Farrell, C.6
Kingma, D.W.7
Horwitz, M.E.8
Mansfield, E.9
Holland, S.M.10
O'Shea, J.J.11
Rosenberg, H.F.12
Malech, H.L.13
Kastner, D.L.14
-
5
-
-
0025854580
-
Colchicine prophylaxis in Familial Mediterranean Fever: Reappraisal after 15 years
-
Ben-Chetrit E, Levy M. Colchicine prophylaxis in Familial Mediterranean Fever: reappraisal after 15 years. Semin Arthritis Rheum. 1991; 20: 241-246.
-
(1991)
Semin Arthritis Rheum
, vol.20
, pp. 241-246
-
-
Ben-Chetrit, E.1
Levy, M.2
-
6
-
-
1442274819
-
Colchicine Nonresponsiveness in Familial Mediterranean Fever: Clinical, Genetic, Pharmacokinetic, and Socioeconomic Characterization
-
DOI 10.1053/S0049-0172(03)00137-9
-
Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, Langevitz P, Livneh AR. Colchicine nonresponsiveness in Familial Mediterranean Fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum. 2004; 33: 273-282. (Pubitemid 38280826)
-
(2004)
Seminars in Arthritis and Rheumatism
, vol.33
, Issue.4
, pp. 273-282
-
-
Lidar, M.1
Scherrmann, J.-M.2
Shinar, Y.3
Chetrit, A.4
Niel, E.5
Gershoni-Baruch, R.6
Langevitz, P.7
Livneh, A.8
-
7
-
-
47349101976
-
Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever
-
Tweezer-Zaks N, Rabinovich E, Lidar M, Livneh A. Interferon-alpha as a treatment modality for colchicine-resistant Familial Mediterranean Fever. JRheumatol. 2008; 35: 1362-1365. (Pubitemid 352000785)
-
(2008)
Journal of Rheumatology
, vol.35
, Issue.7
, pp. 1362-1365
-
-
Tweezer-Zaks, N.1
Rabinovich, E.2
Lidar, M.3
Livneh, A.4
-
8
-
-
5444235782
-
The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant Familial Mediterranean Fever patients
-
Calguneri M, Apras S, Ozbalkan Z, Ozturk MA, Ertenli I, Kiraz S. The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant Familial Mediterranean Fever patients. Clin Exp Rheumatol. 2004; 22 (Suppl): 41-44.
-
(2004)
Clin Exp Rheumatol
, vol.22
, Issue.SUPPL.
, pp. 41-44
-
-
Calguneri, M.1
Apras, S.2
Ozbalkan, Z.3
Ozturk, M.A.4
Ertenli, I.5
Kiraz, S.6
-
9
-
-
5444253280
-
The effect of interferon alpha administration on acute attacks of Familial Mediterranean Fever: A double-blind, placebo-controlled trial
-
Tunca M, Akar S, Soyturk M, Kirkali G, Resmi H, Akhunlar H, Gonen O, Gallimore JR, Hawkins PN, Tankurt E. The effect of interferon alpha administration on acute attacks of Familial Mediterranean Fever: A double-blind, placebo-controlled trial. Clin Exp Rheumatol. 2004; 22 (Suppl): 37-40.
-
(2004)
Clin Exp Rheumatol
, vol.22
, Issue.SUPPL.
, pp. 37-40
-
-
Tunca, M.1
Akar, S.2
Soyturk, M.3
Kirkali, G.4
Resmi, H.5
Akhunlar, H.6
Gonen, O.7
Gallimore, J.R.8
Hawkins, P.N.9
Tankurt, E.10
-
10
-
-
4444220135
-
The, Z. efficacy of interferon-alpha in a patient with resistant Familial Mediterranean Fever complicated by polyarteritis nodosa
-
Calguneri M, Apras Ozbalkan S, Ozturk MA. The, Z. efficacy of interferon-alpha in a patient with resistant Familial Mediterranean Fever complicated by polyarteritis nodosa. Intern Med. 2004; 43: 612-614.
-
(2004)
Intern Med
, vol.43
, pp. 612-614
-
-
Calguneri, M.1
Apras Ozbalkan, S.2
Ozturk, M.A.3
-
11
-
-
0030803601
-
The efficacy of interferon alpha on colchicine-resistant Familial Mediterranean Fever attacks: A pilot study
-
Tunca M, Tankurt E, Akbaylar AH, Akar S, Hizli N, Gonen O. The efficacy of interferon alpha on colchicine-resistant Familial Mediterranean Fever attacks: a pilot study. Br J Rheumatol. 1997; 36: 1005-1008.
-
(1997)
Br J Rheumatol
, vol.36
, pp. 1005-1008
-
-
Tunca, M.1
Tankurt, E.2
Akbaylar, A.H.3
Akar, S.4
Hizli, N.5
Gonen, O.6
-
12
-
-
4544341107
-
The PYRIN connection: Novel players in innate immunity and inflammation
-
DOI 10.1084/jem.20032234
-
Stehlik C, Reed JC. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med. 2004; 200: 551-558. (Pubitemid 39258304)
-
(2004)
Journal of Experimental Medicine
, vol.200
, Issue.5
, pp. 551-558
-
-
Stehlik, C.1
Reed, J.C.2
-
13
-
-
0036184889
-
Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures
-
Abedat S, Urieli-Shoval S, Shapira E, Calko S, Ben-Chetrit E, Matzner Y. Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures. Isr Med Assoc J. 2002; 4: 7-12. (Pubitemid 34193058)
-
(2002)
Israel Medical Association Journal
, vol.4
, Issue.1
, pp. 7-12
-
-
Abedat, S.1
Urieli-Shoval, S.2
Shapira, E.3
Calko, S.4
Ben-Chetrit, E.5
Matzner, Y.6
|